StemCell Therapy

Multiple Sclerosis

At present there are no treatments that specifically target the abnormal immune responses in MS. Current approaches, such as interferon, copaxone, or immune suppressants all act in a nonspecific manner blocking immune responses against the myelin sheath. While these approaches are useful for reducing the severity of disease, they do not repair the damage to nervous system tissue that has already occurred and therefore they cannot cure multiple sclerosis.

Mesenchymal stem cells (MSCs), have immune regulatory properties which may stop the immune system from attacking the myelin sheath.

Mesenchymal stem cells may also potentially help remyelination (re-generation of the myelin sheath) of the affected neurons. Currently, the University of Cambridge is conducting formal clinical studies using mesenchymal stem cells for treatment of MS.

VIDEO Professor Arnold Caplan The father of mesenchymal stem cells from Case Western Reserve University discusses stem cell therapy for MS.

The adult stem cells used to treat MS at the Stem Cell Institute are called allogeneic mesenchymal stem cells. They are harvested from human umbilical cords donated after normal, healthy births. Each mother is tested for infectious diseases and has her medical history screened. Proper consent is received from each family prior to donation.

Before they are approved for use in treatment all umbilical cord-derived stem cells are screened for infectious diseases to International Blood Bank Standards.

Only about 1 in 10 donated umbilical cords pass our rigorous screening process.

Through retrospective analysis of our cases, weve identified proteins and genes that allow us to screen several hundred umbilical cord donations to find the ones that we know are most effective. We only use these cells and we call them golden cells.

We go through a very high throughput screening process to find cells that we know have the best anti-inflammatory activity, the best immune modulating capacity, and the best ability to stimulate regeneration.

The bodys immune system is unable to recognize umbilical cord-derived mesenchmyal stem cells as foreign and therefore they are not rejected. HUCT stem cells have been administered thousands of times at the Stem Cell Institute and there has never been a single instance rejection (graft vs. host disease). Umbilical cord-derived mesenchymal stem cells also proliferate/differentiate more efficiently than older cells, such as those found in the fat and therefore, they are considered to be more potent.

VIDEO Watch Professor Arnold Caplan explain how this works.

The HUCT stem cells are administered intravenously by a licensed physician. Additional methods may be recommended.

Below is an example of a typical multiple sclerosis treatment protocol:

All patients receive a one month supply of Stem Kine supplement (only after medical evaluation in Panama)

*After examining each patients medical history and other medical information our team of physicians will recommend a specific treatment protocol. Your recommended protocol may differ from the example given above.

We want to help our patients and we care about how you are doing after you return home. Proper follow-up also helps us evaluate treatment efficacy and improve our multiple sclerosis treatment protocol based on observed outcomes.

Therefore, one of our staff will be contacting you after 1 month, 3 months, 4 months, and 1 year after the treatment to follow up on your condition.

Yes, you may. Once you been evaluated and approved for treatment by our medical team, your patient coordinator will be happy to put you in touch with a few.

We also welcome you to view multiple sclerosis patient testimonials, news articles and videos. Please take a look!

You may contact us by telephone 1 (800) 980-STEM (toll-free in US) and 1 (954) 358-3382.

To apply for stem cell treatment, please complete this Patient Application Form.

See more here:
Stem Cell Therapy || Multiple Sclerosis Stem Cell ...

This entry was posted on August 4, 2016 at 9:37 am and is filed under Stem Cell Panama. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed. |